If you need more lookups,
subscriptions start at $34 USD/month.
Daniela Penston Location
London, GB
Daniela Penston Work
Director and Team Lead Discovery and New Technologies @ (September 2023 - Present)
Senior Lead Non-Clinical Development @ (June 2021 - September 2023)
Senior Scientist II @ (January 2020 - May 2021)
Senior Scientist @ (January 2019 - January 2020)
Research Scientist @ (June 2017 - January 2019)
Research Associate - CAR T-cell Immunotherapy @ (January 2016 - June 2017)
PhD Cancer Research - CAR T-cell Immunotherapy @ (January 2013 - January 2016)
Research Assistant @ National Center for Infectious and Parasitic Diseases (May 2012 - December 2012)
MSc Molecular Medicine @ (October 2010 - October 2011)
Daniela Penston Education
King's College London
Doctor of Philosophy - PhD (Cancer Immunotherapy)
Daniela Penston Skills
Bacterial Transformation
Bispecific antibodies
CAR T-cells
Cell Biology
Cell Culture
DNA Extraction
Data Analysis
Drug Development
Drug Discovery
FACS
Flow Cytometry
Gel Electrophoresis
Gel Extraction
IMPD
IND
Immunoprecipitation
Immunostaining
Life Sciences
Matlab
Microsoft Office
Miniprep
Molecular Biology
Molecular Cloning
PCR
Polymerase Chain Reaction (PCR)
PowerPoint
Primer Design
Project Leadership
RNA Isolation
RNA extraction
Real-Time Polymerase Chain Reaction (qPCR)
Regulatory Guidelines
SDS-PAGE
Site-directed Mutagenesis
Team Management
Transduction
Vector Design
Western Blotting
qPCR
real-time PCR
Daniela Penston Summary
Daniela Penston, based in London, GB, is currently a Director and Team Lead Discovery and New Technologies at Quell Therapeutics. Daniela Penston brings experience from previous roles at Affimed and Autolus Ltd.. Daniela Penston holds a Doctor of Philosophy - PhD in Cancer Immunotherapy @ King's College London. With a robust skill set that includes Bacterial Transformation, Bispecific antibodies, CAR T-cells, Cell Biology, Cell Culture and more. Daniela Penston has 1 emails on RocketReach.
Looking for a different Daniela Penston?
Find contact details for 700 million professionals.